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KCC2 is a neuron-specific chloride-
extruder that shapes cortical
development.
Changes in the strength of GABAergic
synapses brought about by up- and
downregulation of Cl− extrusion by
KCC2 exert a major effect on neuronal
plasticity and network functions.
The structural interactions of the CKCC2, best known as the neuron-specific chloride-extruder that sets the strength
and polarity of GABAergic currents during neuronal maturation, is amultifunctional
molecule that can regulate cytoskeletal dynamics via its C-terminal domain (CTD).
We describe the molecular and cellular mechanisms involved in the multiple
functions of KCC2 and its splice variants, ranging from developmental apoptosis
and the control of early network events to the formation and plasticity of cortical
dendritic spines. The versatility of KCC2 actions at the cellular and subcellular
levels is also evident in mature neurons during plasticity, disease, and aging.
Thus, KCC2 has emerged as one of the most important molecules that shape the
overall neuronal phenotype.terminus of KCC2 regulate signaling
pathways involved in early neuronal sur-
vival, spinogenesis, and glutamatergic
synaptic transmission.
The recently discovered tertiary and qua-
ternary structures of KCC2 and other
cation/chloride cotransporter (CCC)
members provide first insights into their
functions at an atomic level.
The multisite phosphorylation code of
KCC2 controls itsmembrane expression
and stability, as well as its intrinsic trans-
port rate during development, plasticity,
and disease.
KCC2 mutations linked to epilepsy and
autism spectrum disorder (ASD) disrupt
both ion transport-dependent and
-independent KCC2 functions, suggest-
ing a novel molecular basis for CNS dis-
orders related to the structural roles of
KCC2.
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Fast synaptic transmission relies on ion fluxes through ligand-gated ion channels. Although the
default state of a cell is to have a high intracellular chloride concentration ([Cl−]i), mature neurons
in the CNS have evolved a unique ability to maintain a low [Cl−]i, which is needed for the genera-
tion of hyperpolarizing Cl− currents across GABAA and glycine receptors (GABAARs and GlyRs)
[1]. This specialization comes at a high energy cost [2], and is brought about by upregulation of
the neuron-specific K-Cl cotransporter KCC2 during neuronal maturation [1,3,4].
KCC2 belongs to the evolutionarily ancient family of SLC12 cation/chloride cotransporters
(CCCs) (Box 1; for KCCs and NKCCs, see Glossary) that have their roots in a single gene in
Archaea, from which numerous duplication events in both archaeans and eukaryotes have led
to the divergence and neofunctionalization of the paralogous CCC subfamilies [5]. Possibly be-
cause of a primordial role in cellular volume regulation, CCCs have evolved to communicate
with the actin cytoskeleton. Indeed, KCC2 has emerged as an important player in controlling
actin dynamics during neuronal development and plasticity [6–9].
The functional upregulation of KCC2-mediated K-Cl cotransport in hippocampal and neocortical
neurons underlies the hyperpolarizing shift in GABAergic currents which takes place postnatally in
rats and mice [3], but it has become clear that KCC2 is expressed at low but functionally significant
levels pre- and perinatally. KCC2 acts in an ion transport-independent manner as an antiapoptotic
factor in projection neurons in the prenatal mouse neocortex [10]; in the perinatal mouse and rat hip-
pocampus transport-functional KCC2 decreases the depolarizing driving force of GABAAR-mediated
currents (DFGABA), thereby influencing spontaneous network events at their developmental onset [11].
In this review we highlight the developmental paths from KCC2 protein expression to its multiple
functions, and discuss the wide variety of post-translational mechanisms which control these
phenomena. The versatility of KCC2 regulation at the cellular and subcellular levels is also evident
in mature neurons during plasticity, disease, and aging. Thus, KCC2 has emerged as one of the
most important molecules that shape the overall neuronal phenotype (Figure 1).378 Trends in Neurosciences, May 2021, Vol. 44, No. 5 https://doi.org/10.1016/j.tins.2021.01.004
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Box 1. Molecular Structure of CCCs
Despite the fact that CCCs were cloned >20 years ago, their tertiary and quaternary structures remained unknown until
very recently. The development of cryogenic electron microscopy (cryo-EM) and single-particle image processing brought
several reports describing high-resolution structures of zebrafish [126] and human [127] NKCC1, mouse KCC4 [128], as
well as human KCC1 [129,130], KCC2/KCC3 [131], and KCC2/KCC3/KCC4 [132].
All these studies determined a common transmembrane domain (TMD) in KCCs and NKCCs that consists of 12 trans-
membrane (TM) helices, the first 10 of which form the ion-translocating path in all CCCs. The NKCC and KCC structures
show remarkable conservation of the K+ binding site [126,129,133] that is coordinated by five amino acids (N131, I132,
Y216, P429, and T432 in hKCC1 [129]). The positions of the Cl− binding sites were resolved in hKCC1 [129], mKCC4
[128], hKCC4 [132], and DrNKCC1 [126]. Surprisingly, two Cl− sites were discovered in hKCC1 and hKCC4: one that is
directly involved in K-Cl cotransport, and a second that allosterically facilitates the occupancy of the former. In hKCC1,
the Cl− in the transport site is coordinated by main-chain amide groups of G134, V135, I136, the hydroxyl group of
S430, and K+ ion, whereas the allosteric coordination center consists of the amide groups of G433, I434, M435, and
the hydroxyl group of Y589 from TM10 [129].
The N-terminal domains of CCCs yield poor resolution by EM, indicating high conformational flexibility. Interestingly, the
human KCC2/KCC3 [131] and KCC2/KCC4 [132] structures have a ~25 amino acid N-terminal loop that blocks the cy-
toplasmic entry of the translocation pore. Consistent with the function of this loop as a modulator of the transporter, its
deletion [131] or mutation [132] activated ion transport.
tWith the unique exception of the monomeric mKCC4 structure [128], all CCCs showed a dimeric assembly, as had
been predicted before. The dimer interface comprises TMDs and C-terminal domains (CTDs) in a swapped conforma-
tion in which the CTD of one subunit is placed under the TMD of the other (Figure 2B). The swapping occurs in the
'scissor helix' region that connects TMD and CTD within each subunit, as shown for all hKCCs [129,130] and
DrNKCC1 [126]. The extracellular domains stabilize hKCC1 [129,130] but not hKCC2, hKCC3, or hKCC4 dimers
[131,132]. It is worth pointing out here that the SDS-resistant higher homo-oligomers of KCC2 in western blots are ob-
viously a result of the well-known aggregation of membrane proteins subjected to heating or acidic pH [134]. In partic-
ular, the amount of KCC2 oligomers in SDS gels bears no relation to the presence of functional dimers in the original
tissue.
As a whole, the accumulating knowledge on the molecular structure of KCC2 provides information that can be used in
studies on the molecular mechanisms and modulation of ion transport by KCC2 inhibitors (reviewed in [133]) and activa-
tors [123,124], and by interacting molecules, including those depicted in Figure 1 in the main text.
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OPEN ACCESSModulation of KCC2 Activity in the Perinatal Period and Beyond
During the development of various parts of the vertebrate CNS, GABAARs and GlyRs mediate
a depolarizing effect [1,12] which depends on the high [Cl−]i concentration maintained by
the Na-K-2Cl cotransporter NKCC1 [12–14]. In immature pyramidal neurons of rats and
mice, the GABAergic depolarization is seen prenatally and during the first postnatal week
[11,12,15,16]. The depolarizing actions of GABA have long been known to play an important
role in cell proliferation and survival, migration, differentiation, and early network wiring, but
direct evidence for depolarizing GABA signaling in vivo is only starting to emerge [17,18]. It is
important to note that depolarizing GABAergic transmission in immature networks in vivo can
be functionally excitatory, as seen in mouse hippocampus [18], or inhibitory, as demonstrated
in mouse neocortex [17–19].
KCC2 levels in the hippocampus and cortex rise steeply during the first 2 postnatal weeks,
paralleled by enhanced Cl− extrusion and by a shift from depolarizing to hyperpolarizing in the
reversal potential of GABAergic currents (EGABA) [20,21] (Box 2). This developmental EGABA
shift, which is an excellent indicator of the stage of maturation of distinct neuronal populations
[3], has by now been described in most types of central neurons [1,22]. In the human neocortex,
massive upregulation of KCC2 expression is observed during the second half of gestation
[23,24].Trends in Neurosciences, May 2021, Vol. 44, No. 5 379
Glossary
Developmental apoptosis: a form of
programmed cell death that occurs
naturally in embryonic development. It
sculpts the organism by removing
unwanted structures and by controlling
the number and quality of cells that are
initially produced in excess.
Early network events: spontaneous
synchronous network activity during the
period of initial network wiring. In the
hippocampus, depolarizing GABAergic
transmission promotes intrinsic bursting
of the glutamatergic network. As the
neuronal network matures, the discrete
events become replaced by continuous
oscillations (second postnatal week in
rat and mouse neocortex, and around
the time of full-term birth in human
cortical electroencephalography).
EGABA: the membrane potential at
which the current through open
GABAARs reverses its polarity (reversal
potential). EGABA depends on the
intracellular and extracellular
concentrations of Cl− and HCO3
−
according to the Goldman–Hodgkin–
Katz equation, and intracellular HCO3
−
therefore has a very small effect on
EGABA in neurons with a high intracellular
Cl− concentration. However, in mature
neurons with a low [Cl−]i, the
bicarbonate-mediated current
component can be larger than that
mediated by Cl−.
Ionic plasticity: a change in the
strength of GABAergic or glycinergic
synapses, that is brought about by
temporal and spatial changes in the
driving force of the GABAAR-mediated
current. These are caused by (i) activity-
dependent Cl− redistribution and, in a
wider time span, by (ii) changes in the
membrane expression of functional Cl−
transporters and Cl− permeable
channels.
KCCs: secondary active K-Cl
cotransporters that under physiological
conditions actively extrude Cl− from the
cell, using the energy of the
plasmalemmal K+ gradient. There are
four different isoforms (KCC1–4), of
which KCC2 is the only neuron-specific
transporter.
NKCCs: secondary active Na-K-2Cl
cotransporters thatmoveK+ andCl− into
the cell using energy derived from the
plasmalemmal Na+ gradient. There are
two isoforms (NKCC1 and NKCC2), and
NKCC1 is expressed in various tissues
and cell-types, including CNS neurons
and glia. In developing neurons, NKCC1
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transport-active at the time when the first early network events (the so-called giant depolarizing
potentials, GDPs, in in vitro preparations) are observed [11]. Notably, the specific KCC2 inhibitor
VU0463271 [25] causes a pronounced enhancement of GDP activity in field-potential recordings,
an enhancement of the depolarizing drive of GABAergic interneurons that facilitates spiking of
CA3 pyramidal neurons, and collapse of an experimentally induced somatodendritic Cl− gradient
[11] that provides a quantitative read-out of Cl− extrusion efficacy ([26]; also [27,28]).
An important but often ignored aspect of KCC2 regulation is that the Slc12a5 gene generates
two splice variant proteins, KCC2a and KCC2b (Figure 2), via the use of alternative promoters.
In fact, one of the earliest attempts to generate a KCC2 knockout (KO) mouse [29] resulted
(as discovered later [30,31]) in a KCC2b-specific KO mouse that has seizures but can survive
for up to 2 weeks. Both KCC2 isoforms have an influence on respiratory pattern generation
after birth [32,33], and the full KCC2 KO mouse is unable to breathe and dies at birth [20].
Notably, KCC2a and KCC2b expression show a twofold and 20-fold increase, respectively,
during cortical development in themouse [34]. Thus, although KCC2b is the predominant isoform
in the mature brain, KCC2a may have functions that have so far gone unnoticed (Box 3).
In mature neurons, the various postsynaptic structures of GABAergic synapses are highly
dynamic and display short-term and long-term plasticity [35]. However, DFGABA (and thus the
efficacy of inhibition) can also undergo large changes depending on the cellular Cl− load and the
efficacy of Cl− extrusion (originally termed by us ionic plasticity [36]). The fastest effects of ionic
plasticity on DFGABA, at timescales of seconds, are caused by activity-dependent redistribution
of ions, whereas longer-lasting adjustments, from minutes to days and even years, are caused
by changes in post-translational and genomic regulation ([37] for review). In addition to these
temporal domains of ionic plasticity in GABA-mediated signaling, there are basically two types of
mechanisms that can lead to spatial gradients of Cl− in neurons: (i) under steady-state conditions
in quiescent neurons, Cl− gradients do exist, and these are attributable to nonhomogeneous distri-
bution of KCC2 and NKCC1 [38–41] ([42] for discussion on NKCC1 expression in the brain).
(ii) Moreover, in the living brain, neuronal activity is likely to impose fast changes in the
local Cl− 'loads' originating from GABAARs and other Cl
−-permeable channels (see earlier) be-
cause of abrupt and large changes in the membrane potential (Vm) and, consequently, in the
driving force for Cl− (DFCl = Vm − ECl). Current imaging techniques do not permit direct obser-
vation of these fast Cl− shifts, but that they must exist can be readily deduced on the basis of
what is known of the electrophysiology of GABAergic transmission and fast ionic plasticity
([1] for discussion).
Downregulation of KCC2 has been reported in neuronal trauma and various CNS diseases
[43–48]. These changes often lead to a depolarizing shift in steady-state GABAAR responses,
consistent with a general trauma-induced dedifferentiation at the level of transcription and
translation, including loss of spines. Furthermore, several types of conditions ranging from neuro-
endocrine adaptations [49] to psychiatric disorders [50] are associated with marked changes in
KCC2 expression and function.
Regulation of KCC2 (De)Phosphorylation
A large amount of evidence points to (de)phosphorylation cascades as major modulators of
KCC2 functionality. In general, NKCCs are activated whereas KCCs are inhibited by phosphory-
lation [51,52] (but see below for protein kinase C (PKC)). An interesting aspect of their molecular
evolution is that the C terminus of KCC2 and the N terminus of NKCC1 have a similar four amino
acid phosphorylation motif [53] that is possibly involved in these opposite effects. In KCC2, the380 Trends in Neurosciences, May 2021, Vol. 44, No. 5
maintains the high intracellular Cl−
concentration needed for depolarizing
GABAergic transmission, whereas in
healthy mature neurons NKCC1 actions
seem to be mainly confined to the axon
initial segment and probably also to
axons.
Shunting inhibition: in standard
textbooks, ‘hyperpolarizing
postsynaptic inhibition’ mediated by
GABAARs implies that EGABA < Vm at
rest, which is maintained by KCC2,
whereas ‘shunting inhibition’ refers to
short circuiting of the membrane by the
GABAAR-mediated conductance to the
resting Vm level (EGABA ≈ Vm) as typically
measured in brain slices. However, this
kind of distinction is not valid under in
vivo conditions, in which resting Vm is ill-
defined and the activity-dependent
intraneuronal Cl– load is high. Thus, in
vivo the stability of shunting inhibition
also requires active Cl– extrusion by
KCC2 to maintain the membrane
potential at a more negative level than
the action potential threshold.
Spinogenesis: the generation of
dendritic spines. In pyramidal neurons,
excitatory synapses are predominantly
located on dendritic spines – small
protrusions on neuronal dendrites.
Newly formed spines often have a small
head diameter and may lack synaptic
contacts.
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These residues are targeted by kinases of theWNK (With-No-Lysine) family, which act as sensors
of [Cl−]i [54]. WNK kinases are unique in that Cl
− inhibits their autophosphorylation and
consequent kinase activation [54]. Mature neurons express mainly WNK1 and, to a lesser extent,
WNK3 [55]. Although WNK1 mRNA levels remain stable during cortical and hippocampal devel-
opment, WNK3 mRNA levels decrease during the developmental period of KCC2 upregulation
[52]. When active (i.e., at low [Cl−]i), WNKs inhibit KCC2 activity by increasing KCC2 C-terminal
phosphorylation via STE20/SPS1-related proline/alanine-rich kinase (SPAK) and oxidative stress
response kinase 1 (OSR1) kinases (T1007 site), or via another kinase that remains to be identified
(T906 site) [56,57]. Although most of the available literature suggests that (de)phosphorylation of
T906/T1007 regulates KCC2membrane expression [58–60], possibly through changes in KCC2
membrane diffusion [55], some studies suggest that (de)phosphorylation of T906/T1007 would
instead regulate its intrinsic transport activity [53,61–63].
In line with the developmental EGABA shift, WNK1-mediated T906/T1007 KCC2 phosphorylation
decreases with neuronal maturation in vitro [60]. Mass spectrometric analysis of whole mouse
brains has shown a decrease in the proportion of KCC2 molecules that are phosphorylated at
T906 from ~20% at postnatal day (P)0 to ~10% by P3, and to undetectable levels after P21
[53]. Transgenic KCC2 mice with mutations affecting T906/T1007 phosphorylation have con-
firmed the importance of the threonine sites for KCC2-mediated chloride transport. Homozygous
knockin mutant mice with phosphomimetic threonine to glutamate substitutions (T906E/T1007E)
are unable to breathe and die shortly after birth [61] in a manner similar to the full constitutive
KCC2 KO mice [20].
A large number of phosphorylation sites have been described in different domains of KCC2
[57,61,63–65], including the alternatively spliced N-terminal region (T6 [57,65]). Most work on
the activation and inhibition of CCCs in neurons has focused on the role of kinases. It is therefore
important to note that, in contrast to the mechanisms described earlier, KCC2 regulation via
serine 940 phosphorylation by PKC and PP1 (protein phosphatase 1) [66–68] enhances the
stability (amount) of plasmalemmal KCC2, and thereby increases the efficacy of K-Cl cotransport
[28,66–68].
Functional regulation of KCC2 by (de)phosphorylation can be very fast. Chloride influx and
subsequent WNK inhibition promotes KCC2 membrane diffusion within tens of seconds [55],
and the broad-spectrum kinase inhibitor staurosporine enhances KCC2-mediated K-Cl cotrans-
port activity in cultured hippocampal neurons within a fewminutes [26], which can be attributed to
impaired WNK-SPAK/OSR1-mediated phosphorylation of KCC2 [64].
The phosphorylation cascades aremodulated in an activity-dependent manner, as seen in exper-
iments in adult mice in which pentylenetetrazole-induced seizures activated both WNK1 and
SPAK/OSR1 to increase KCC2 T906 and T1007 phosphorylation [55]. In P5–P7 rats, a
kainate-induced seizure episode enhanced Cl− extrusion in CA1 neurons in <30 minutes, with
an apparently TrkB-dependent increase in KCC2 surface expression and no change in total
KCC2 protein [69]. An interesting question concerns whether distinct (de)phosphorylation mech-
anisms acting in subcellular compartmentsmight contribute to the variation of steady-state EGABA
values that have been observed along the axo-somato-dendritic axis [38–41,70].
Based on the aforementioned studies, it seems that (de)phosphorylation-controlled changes in
KCC2 functionality are largely attributable to mechanisms that act at the level of (i) subcellular
targeting, membrane trafficking, and stability of the transporter protein. (ii) Allosteric regulationTrends in Neurosciences, May 2021, Vol. 44, No. 5 381
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Figure 1. Multiple Functions of KCC2 in Cortical Development and Trauma. (A) KCC2 promotes the survival of migrating pyramidal neurons during the first wave
of apoptosis independently of its functions as a K-Cl cotransporter. Signaling cascades triggered by the C terminus act to prevent cofilin hyperphosphorylation, which
controls cytosolic release of cytochrome c and apoptosis. (B) KCC2 shapes the formation of emerging neuronal circuits through its ion transport-dependent and
-independent mechanisms. In the perinatal rat and mouse hippocampus, KCC2-mediated Cl− extrusion is already functional and delimits the depolarizing GABAA
receptor (R)-mediated transmission and synchronous network events (left panel). KCC2 also plays a transport-independent structural role in dendritic spinogenesis
(Figure legend continued at the bottom of the next page.)
Trends in Neurosciences
382 Trends in Neurosciences, May 2021, Vol. 44, No. 5
OPEN ACCESS
Box 2. The 'Why's of KCC2 Developmental Upregulation
(i) Cl− extrusion is a specialized feature of mature neurons. During the early development of cortical structures, the
principal neurons are not yet coupled into functional networks, and they do not need a specific Cl− extrusion
mechanism. This is because the immature neurons communicate via gap junctions and paracrine mechanisms,
and, in the near-absence of electrical activity such as glutamatergic excitatory postsynaptic potentials (EPSPs) and
trains of action potentials, there is little Cl− uptake driven by depolarizing Vm fluctuations [2]. Cl
− levels are therefore
maintained by NKCC1 and the time-average Vm which set ECl and consequently EGABA at a depolarizing level. A
rough calculation, based on an ion turnover rate of 4000/s for NKCC1 [135] and a standard GABAAR conductance
of 28 pS, shows that, to maintain a constant 20–40 mV driving force of a depolarizing Cl− current, the number of
plasmalemmal NKCC1 transporters must be up to 500–1000-fold higher than that of open GABAAR channels.
(ii) In the early stages of network formation and the establishment of electrical synaptic contacts, cortical networks
generate sparse and discontinuous 'events' (e.g., GDPs observed in slice preparations) in which depolarizing
GABA plays a permissive (or facilitatory) role, whereas the glutamatergic pyramidal neurons have an instructive role
in the temporal patterning of these events [136]. During this developmental time-window, transport-functional
KCC2 expression commences to deal with the enhanced, activity-dependent Cl− load. However, EGABA remains
depolarizing despite the observable [11] net Cl− extrusion via KCC2. This is a transitional stage, which is perinatal
in rats and mice, but in many species, including guinea pigs, monkeys and human, occurs prenatally.
(iii) During further maturation, the network events become more frequent, and KCC2 becomes progressively upregulated.
At this stage, EGABA shows a shift to more negative levels, paralleling the steep increase in cellular connectivity based on
the fast maturation of both glutamatergic and GABAergic synapses. This increase in network connectivity is manifest in
the electroencephalogram (EEG), in which the discrete network events are gradually replaced by ongoing oscillations.
The depolarizing-to-hyperpolarizing EGABA shift is restricted to the prenatal period in guinea pigs and monkeys
[3,137]; in humans, it occurs before and around full-term birth [23,24], whereas in rats andmice it takes place postnatally
[3].
(iv) Once the neuronal connectivity and ongoing network activity are becoming fully mature, the time-average Cl− load, the
expression level of KCC2, and the hyperpolarizing EGABA shift reach their peak levels. Here, it should be also noted that
much of the inhibitory effect of GABAR activation is based on shunting inhibition. In parallel, neuronal ionic trafficking
and energy metabolism reach their maxima, and this has numerous physiological consequences, including the
characteristically high dependence of neuronal survival on the availability of oxygen. Notably, neuronal damage
leads to loss of KCC2 and to 'reversal' of the developmental EGABA shift, which may be part of a wider picture of
dedifferentiation that is necessary for neuronal survival under adverse conditions.
Trends in Neurosciences
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thought to have occurred in several studies on KCC2 [53,61–63], and the data suggest that the
intrinsic transport activity of KCC2 is increased by phosphorylation of T934 or S937 [63], and de-
creased by phosphorylation of T906 and T1007 [53]. Clearly, if the mechanisms underlying (i) and
(ii) above are shared during a (de)phosphorylation event, it will be very difficult to establish their rel-
ative contributions to net changes in KCC2 function.
In addition to the above, a large number of mechanisms, including pronounced modulation of
KCC2 gene transcription by miRNAs [72], KCC2 clustering in lipid rafts [68,73,74], and KCC2
degradation by calpain [68,75,76] are known to contribute to what is currently lumped together
into the ambiguous 'KCC2 activation/inactivation' terminology. Notably, however, KCC2mutations
can have an effect on all aspects of KCC2 functions, including intrinsic ion-transport efficacy,
membrane trafficking, and the role of KCC2 in spine formation and developmental apoptosis
(Box 4).(right panel). (C) During further neuronal maturation, robust upregulation of KCC2 expression and the consequent increase in Cl− extrusion lead to hyperpolarizing
GABAAR-mediated chloride currents (lower panel). Membrane expression of KCC2 is regulated by activity-dependent post-translational modifications including
(de)phosphorylation cascades, which control the exo- and endocytosis and lateral diffusion of KCC2. KCC2 interacts directly with a variety of plasmalemmal molecules,
as shown in the illustration. In dendrites of pyramidal neurons, KCC2 plays a structural, ion transport-independent role in regulating actin dynamics within spines through
cofilin phosphorylation (upper panel). KCC2 also binds to the actin cytoskeleton through 4.1N, which regulates the lateral diffusion of KCC2 and AMPA receptors
(AMPARs) near excitatory synapses [27]. (D) KCC2 downregulation upon neuronal trauma leads to a depolarizing shift in GABAAR responses, consistent with the
observed trauma-induced dedifferentiation [147,148]. KCC2 is C-terminally cleaved by the Ca2+- and brain-derived neurotrophic factor (BDNF)-activated protease calpain
[68,75], and KCC2 transcription is downregulated through TrkB signaling [43]. Abbreviations: NMDAR, N-methyl-D-aspartate receptor; PKC, protein kinase C; PP1,
protein phosphatase 1.




























Figure 2. KCC2 Structure, Illustrated Along with Important Regulatory Phosphoresidues and Known Human
Mutations. (A) Schematic representation of KCC2 secondary structure, with known human mutations (black) and some of
the important phosphorylation sites (blue). KCC2 has two variants, KCC2a and KCC2b, which are generated by transcription
from independent promoters and differ in their first exon. Only the KCC2a isoform contains the conserved SPAK/OSR1
binding site (RFTV). The autoinhibitory N-terminal loop (A66–N83 in KCC2b [131] and V81–N107 in KCC2a [132], Box 1)
(red) in the entry of the cytosolic vestibule functions as a blocker. The amino acid numbering in the figure is according to
the human KCC2b isoform. (B) Cryo-electron microscopy (cryo-EM) structure of the human KCC2 dimer in which the two
monomers are indicated in different colors; glycans are shown in gray. The dimer has a domain-swapped architecture in
which the C terminus of one monomer is located beneath the transmembrane domain of the other one. The image was
created with the Mol* molecular graphics tool [149] using human KCC2 atomic coordinates reported previously [131] and
deposited in the Protein Data Bank (Research Collaboratory for Structural Bioinformatics [150]) under identification
number 6M23. Broken lines represent regions that are poorly resolved in the cryo-EM structure.
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The steepest phase of cortical KCC2 upregulation in rats and mice as well as in humans coincides
with themost intense period of both glutamatergic [77,78] andGABAergic synaptogenesis [78,79].
There is also a remarkable spatial coincidence between KCC2 upregulation, spinogenesis, and
glutamatergic innervation [27,68,80], and it is now well established that KCC2 plays a structural,
transport-independent role in the generation of dendritic spines and likely acts as a synchronizing
factor in development of functionally excitatory and inhibitory synapses.
Depletion and overexpression of KCC2 in developing cortical and hippocampal pyramidal neurons
have both been shown to perturb the formation of functional synaptic contacts, and to cause an
aberrant, often filopodia-like spinemorphology [6,9,81]. Importantly, the effects on spinemorphology
and functionality are mediated by the C-terminal domain (CTD) because the effects of full-length
KCC2 are mimicked by overexpression of KCC2 constructs consisting only of the CTD [9,81]
or by full-length KCC2 lacking the N-terminal domain (ΔNTD [6,9]). However, the effect of CTD
overexpression depends on the experimental paradigm: in some cases, the structural effects of
full-length KCC2 can be mimicked by CTD overexpression [9,10], whereas in other cases the CTD
can act in a dominant negative manner, mimicking KCC2 downregulation [6,8,27]. Neither the
CTD nor the ΔNTD construct is expected to be delivered to the plasma membrane. In fact, the
KCC2 NTD is required for KCC2 membrane insertion [82], suggesting that the ΔNTD construct
may be retained in intracellular vesicles. Thus, the structural effects of ΔNTD and CTD may be
mediated by the intracellularly exposed CTD in vesicles, or by free cytosolic CTD, respectively.384 Trends in Neurosciences, May 2021, Vol. 44, No. 5
Box 3. Phosphorylation of KCC2: Role of Splice Variants
As explained in the main text, the activity of K-Cl cotransporters is strongly inhibited by phosphorylation of two C-terminal
threonine residues (T906 and T1007 according to human KCC2b notation). KCC2 T906 phosphorylation site is located
within a consensus sequence that is found in all KCCs. Interestingly, a similar sequence is also present in the N terminus
of NKCC1, but, in contrast to KCCs, phosphorylation increases the transport activity. Phosphorylation of the N-terminal
threonines in NKCC1 is mediated by the WNK-SPAK/OSR1 signaling cascade and depends on the N-terminal SPAK-
binding motif positioned upstream of the phosphorylation site [138].
The cytoplasmic N-terminal parts of the K-Cl cotransporters are subject to extensive alternative splicing. KCC2a and
KCC2b splice variants differ only in their first exons that encode the most N-terminal regions (40 amino acids in KCC2a
versus 17 amino acids in KCC2b), and thus the SPAK-binding motif is present in KCC2a but not KCC2b. Accordingly,
in the heterologous HEK293 system, SPAK inhibits the activity of KCC2a [57,65,139] via binding to the KCC2a variant
but not to KCC2b [139]. Thus, a surprising and largely overlooked fact is that, although the SPAK/OSR1 binding motif
is conserved in the N-termini of most CCCs, it is not present at all in the major KCC2 splice variant, KCC2b. This raises
the obvious question whether the N-terminal SPAK motif is dispensable for the regulation of KCC2 by the WNK-SPAK
pathway.
As confirmed by recent cryo-EM [126–132] and X-ray crystal structure [140], CCCs exist as dimers, and both the
cytoplasmic C-terminal and transmembrane domains are involved in dimerization. Thus, KCC2a heterodimerization with
KCC2b in vivo [34] (and the tight interaction of the C-termini within dimers) might allow SPAK/OSR1 to phosphorylate
the C-terminal threonines of both KCC2 variants in the heterodimer. This question should be addressed in future work.
Because of their independent promoters, the expression levels of KCC2a and KCC2b differ during development. The
contribution of KCC2a to total KCC2 protein expression shows a dramatic decrease especially in the neocortex – in mice
from ~65% at E14 to ~5% in the adult [29,31,34]. This fall in the relative KCC2a expression appears to be closely paralleled
by the developmental decrease in T906/T1007 phosphorylation. Thus, it is tempting to speculate that KCC2a–KCC2b
heterodimerization might act as an important mechanism to maintain K-Cl cotransport activity at low levels during early
stages of neocortical development, at the time when KCC2 exerts its structural, antiapoptotic effects and promotes the
survival of migrating projection neurons.
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tion of the actin cytoskeleton. In KCC2-deficient neurons, dendritic spines exhibit a large pool of
stable actin, resulting in reduced spine motility [7]. The effect of KCC2 on actin dynamics is
mediated by the interaction of KCC2 and the β isoform of Rac/Cdc42 guanine nucleotide
exchange factor β-PIX, which through Rac1 GTPase, controls the phosphorylation of one of the
major actin-regulating proteins, cofilin-1 [7,8]. Cofilin is well known for its ability to sever actin
filaments and increase filament turnover [83], and cofilin-mediated changes in actin dynamics are
permissive for the insertion of AMPA receptors (AMPARs) during chemically induced long-term
potentiation (LTP) [84]. In line with this, KCC2 downregulation prevents LTP by decreasing
activity-driven membrane delivery of AMPARs through enhanced cofilin phosphorylation [8].
KCC2 also interacts with the cytoskeleton-associated protein 4.1N [6], and this interaction
hinders lateral diffusion of KCC2 [68] and AMPARs [27] in the vicinity of glutamatergic synapses,
indicating that 4.1N may serve to tether KCC2 to the submembrane actin cytoskeleton. Further
insights into the roles of interactions between KCC2 and 4.1N come from studies on a KCC2
mutant (C586A) that is unable to interact with 4.1N and lacks ion-transport activity. These exper-
iments indicate that, although some of the structural effects of KCC2 overexpression, such as the
increased spine density in cortical neurons [9,81] and perturbed early neural development of
knockin mice [85] depend on this site, actin regulation through cofilin phosphorylation is indepen-
dent of 4.1N [7].
KCC2 physically interacts with a variety of membrane proteins, including the GluK2 subunit of
kainate receptors [86,87] and its auxiliary subunit Neto2 [88], Task-3 (KCNK9) leak potassium
channels [89], and GABAB receptors [90], adding to the variety of ways in which KCC2 can influ-
ence synaptic function and neuronal excitability. KCC2 also interacts with the Na-K-ATPaseTrends in Neurosciences, May 2021, Vol. 44, No. 5 385
Box 4. KCC2 Mutations in Epilepsy
Seizures represent an outcome of highly synchronized neuronal activity which is often (but not always) associated with
impaired inhibition. Mutations in the human KCC2 gene, often biallelic heterozygous, have been linked to cases of febrile
seizures (FS) [28], idiopathic generalized epilepsy (IGE) [122], and epilepsy of infancy with migrating focal seizures (EIMFS)
[141–143].
Most KCC2 mutations identified are single amino acid substitutions scattered through KCC2 domains (see Figure 2A in
main text). Discovered in patients with FS and IGE, the C-terminal substitutions R952H [28,122] and R1049C [122] (using
human KCC2b notation) both reduce Cl− extrusion, but seemingly via different mechanisms: R952H decreases KCC2 sur-
face expression, whereas R1049C affects intrinsic transport rate without changes in surface expression [28,122]. Impor-
tantly, the R952H variant is unable to support the two known ion transport-independent functions of KCC2 – the
maintenance of dendritic spines [28] and the antiapoptotic effect on cortical projection neurons in embryonic neocortex
[10]. Interestingly, histidine is also found at position 952 of the nakedmole rat KCC2 [144], where it may have been favored
by natural selection as one of the striking energy-metabolic adaptations [145] of this eusocial mammal.
Eleven KCC2mutations in total have been described in EIMFS patients [141–143]. Four are in the large extracellular loop 3,
of which three (L288H, W318S, S323P) are located in a region comprising four cysteines that are indispensable for Cl−
extrusion [146] because they stabilize the structure via disulfide bond formation. This region has also several glycosylation
sites which are important for membrane trafficking [4]. Some of the mutants (e.g., L288H) indeed demonstrate reduced
glycosylation and surface expression [141], whereas others (e.g., S323P) do not [142].
Three more EIMFS mutations that impair Cl− extrusion, but not surface expression, are found in the transmembrane
segments TM3 (A191V) and TM6 (L403P, M415V) [141,142], which together with TM1 and TM10 coordinate the K+
and Cl− binding sites. Thus, these three mutations most likely affect the ion translocation process. Notably, Cl− extrusion
activity is completely blocked in the L403Pmutant. The only other EIMFSmutationwith such dramatic loss of function of K-Cl
transport activity is G528D, which resides in the intracellular loop between TM8 and TM9 [141].
One of the EIMFS variants (E50-Q93del), that lacks 44 amino acids including the N-terminal inhibitory loop (Box 1),
demonstrates strongly suppressed Cl− extrusion activity, but intact surface expression. Moreover, two EIFMS mutations
(S748del [142] and R857L [143]) have been found in the C terminus, but their impact on the surface expression and
transport activity of KCC2 remains to be studied.
Froman etiological point of view, it is noteworthy that the IGE and EIMFSmutations so far identified in theKCC2 gene are also
associated with autism and schizophrenia [121]. An intriguing idea which arises here is that loss of transport-independent
functions of KCC2 might contribute to the pathogenesis of neurodevelopmental disorders by increasing apoptosis and
interfering with spinogenesis during early cortical development.
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of an ion-transport metabolon [37]. However, the identity of the Na-K-ATPase isoform (for
instance whether it is α3, rather than α2 as suggested in [37]) has not been rigorously
demonstrated.
The effects of KCC2 downregulation on spine morphology seem to depend on the stage of
maturity, and only an increase in spine head diameter was seen following KCC2 knockdown in
mature hippocampal neurons [27]. In the immature brain, spines are highly motile and often
short-lived [93], whereas in adults they become more stable with a larger head diameter and a
pronounced postsynaptic density [94]. It is thus likely that KCC2-regulated actin dynamics pro-
mote the development of network wiring in immature neurons, and promote network plasticity
at later stages. Indeed, inducible overexpression of KCC2 in adult mice leads to enhanced
spine formation rate during motor learning in layer V pyramidal neurons of the motor cortex [95].
In recent years it has become evident that a substantial fraction of spines are targets of
GABAergic synapses [79,96]. These observations suggest that KCC2 may be involved in the
regulation of intraspine chloride levels. Given the large cation fluxes that take place in spines during
glutamatergic transmission [97], it would not be surprising to observe parallel Cl− shifts mediated by
KCC2 (see Outstanding Questions).386 Trends in Neurosciences, May 2021, Vol. 44, No. 5
Outstanding Questions
Does the (calpain-cleaved) C-terminal
fragment of KCC2 have signaling func-
tions of its own?
Most KCC2 antibodies target the C
terminus. Is it possible that much of the
intracellular KCC2 immunoreactivity re-
ported in the literature reflects the pres-
ence of the C-terminal fragments, and
not the full KCC2 molecule?
Do spines have transport-active KCC2?
If they do, a high Na+ load that replaces
intraspine K+ might reverse local K-Cl
cotransport to an uptake mode.
Is plasmalemmal KCC2 able to switch
between transport-active and transport-
inactive (structural) modes?
To what extent is KCC2 activation
based on trafficking or allosteric
modulation of its intrinsic transport
rate by (de)phosphorylation? How
does this depend on context, such
as developmental stage, disease,
and type of neuron?
What is the physiological significance
of the KCC2a splice isoform during
brain development?
What are the modes of action of drugs
known as 'KCC2 activators', such as
CLP257? Do these drugs have an
effect on spines or apoptosis?
Is downregulation of KCC2 associated
with CNS disorders a maladaptive
(disease-promoting) or an adaptive
(protective) response? Are these two
alternatives context-dependent (e.g.,
early versus chronic trauma)?
KCC2 is a candidate for gene therapy.
Does enhanced Cl− extrusion induced
by KCC2 overexpression in cortical or
hippocampal neurons lead to changes
in spine number and morphology?
SLC12A5 belongs to the top 4.5%
of human genes that are intolerant
to genetic variation (http://chgv.org/
GenicIntolerance/). Thus, SLC12A5
mutations are likely to contribute to
severe CNS disease phenotypes.
What is the overall significance of the
structural role of KCC2 in epilepsy phe-
notypes (Box 4) related to SLC12A5
mutations?
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Two waves of developmental apoptosis sweep the neocortex: the first peaks at around embryonic
day (E)14 in mice and regulates the survival of neuronal progenitors and neuroblasts, and the
second at P2–P9 modulates the survival of differentiating neurons [98]. Although knockdown of
KCC2 in migrating cortical interneurons does not alter their rate of apoptosis [99], little information
has been available, until recently, on the possible involvement of KCC2 in apoptosis of migrating
neocortical pyramidal neurons.
In cortico-hippocampal regions of mice, the earliest KCC2 mRNA and protein expression has
been reported at E15.5 in neocortical pyramidal neurons using RNA-seq analysis [10] and
western blots [21], and by immunohistochemistry of E18.5 pyramidal neurons and interneurons
in the CA3 region [11,21,100]. In humans, KCC2-immunoreactive cells can be seen in the subplate
as early at 16 PCW (postconception weeks) and in the cortical plate at 20 PCW [23,101].
Our group recently used a novel conditional KCC2 mouse model (Kcc2lox/lox) where in utero elec-
troporation of Cre recombinase results in deletion ofKcc2 in individual migrating pyramidal neurons
[10]. Conditional deletion of Kcc2 at E14.5 in a subpopulation of layer II–IV pyramidal neurons
increased the fraction of apoptotic neurons at E16.5 as detected by TUNEL (Terminal
deoxynucleotidyl transferase mediated dUTP Nick End Labeling) staining and cleaved caspase-3
(Cas-3) immunoreactivity. By contrast, no effect was seen on neuronal proliferation or migration.
Strikingly, the KCC2-ablated neurons could be rescued from increased apoptosis equally well
with full-length KCC2 and with transport-deficient truncated KCC2 constructs (CTD and ΔNTD;
see earlier). Thus, plasmalemmal expression of KCC2 is not necessary for the CTD-mediated
antiapoptotic effect, as is the case also with spinogenesis. As discussed earlier, in mature neurons
loss of KCC2 results in enhanced phosphorylation and subsequent deactivation of cofilin [7,8], in-
creasing the stability of actin filaments in dendritic spines. Similarly, the apoptosis elicited by KCC2
deletion was prevented by blocking cofilin hyperphosphorylation using in utero electroporation of a
non-phosphorylatable cofilin mutant [10]. Changes in the phosphorylation and oxidation of cofilin
are a prerequisite for its mitochondrial translocation, which triggers mitochondrial permeabilization
and release of cytochrome c into the cytosol [102], a 'point of no return' in apoptosis.
Interestingly, neocortical Cajal–Retzius neurons (CRNs), that disappear almost entirely during the
second wave of apoptosis, are devoid of KCC2 and persistently express NKCC1 [14,103]. Their
apoptosis is promoted by GABAergic depolarization [104], whereas an opposite effect is seen
following reduction of [Cl−]i by genetic deletion or pharmacological blockade of NKCC1 [104]
as well as by expression of the inward rectifier Kir2.1 [103]. This dependence of CRN apoptosis
on activity is opposite to that of both projection neurons and interneurons, in which suppression
of spontaneous network activity exacerbates apoptosis [105,106].
Concluding Remarks and Future Perspectives
The versatility of KCC2 is reflected by its wide range of functions that span both its canonical role
as a K-Cl cotransporter and its noncanonical roles as a structural and antiapoptotic factor. It has
become increasingly evident that this multifunctionality shows striking cell type- and developmental
stage-dependent variations, including the signaling cascades that target KCC2, some of which are
depicted in Figure 1. For instance, the molecular mechanisms whereby KCC2 is involved in the
formation and dynamics of dendritic spines are not identical in the neocortex and hippocampus
[81], and apparently are not present at all in cerebellar Purkinje neurons [107]. There are also cell
type-specific differences with regard to the ion-transport functions of KCC2; notably, some CNS
neurons, such as dopaminergic neurons in the substantia nigra, are devoid of KCC2 and regulate
their [Cl−]i by means of other transporters, albeit with lower efficacy [108].Trends in Neurosciences, May 2021, Vol. 44, No. 5 387
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GABAergic inhibition during development and disease have received considerable attention,
as described in this review. However, we would argue that solely qualitative observations on
the up- and downregulation of KCC2 functionality – that abound in the literature – are limited
in paving the path to significant conceptual insights into the roles of KCC2. Basic 'design
principles' in physiological systems imply that, during evolution and ontogeny, capacities
are matched to loads in a dynamic manner [109]. Thus, for instance, measurements of the
steady-state EGABA in quiescent neurons in slice preparations do not provide a meaningful
estimate of the efficacy of Cl− extrusion. This conclusion is based on a priori considerations
of leak–pump relations [110] and on data obtained under conditions of experimental [26–28]
or endogenous Cl− load or endogenous Cl− load.
In neurons in vivo, momentary changes in DFGABA are controlled by the dynamics of cellular leak–
pump relationships related to Cl− and HCO3
−, including the redistribution of these two anions
across GABAARs [1]. This type of short-term ionic plasticity can have important consequences
for neuronal network functions. For instance, a recent study has shown that, in the spinal dorsal
horn, a heightened synaptic drive which imposes a high Cl− load leads to a rapid reduction in in-
hibition in lamina I neurons. This, in turn, brings about potentiation of upstream excitatory synap-
ses, resulting in a modality-specific sensitization to thermal and mechanical stimuli [111]. At an
even higher level of neuronal integration, in substantia nigra pars reticulata neurons, dynamic
changes in DFGABA have been implicated in behavioral decision making and olfactory learning
[112,113]. Under pathophysiological conditions such as seizures, activity-dependent ionic shifts
involving intraneuronal Cl− and HCO3
− as well as extracellular K+ become major determinants of
network events [1,37,114,115].
It has been recently observed that changes in the cellular mechanisms supporting learning
and memory in the aging brain involve reorganization of excitatory signaling, whereby high
synapse specificity is replaced by multi-input synapses [116]. A key factor here might be
functional downregulation of KCC2 [117], and this would fit with the general principle that
the dynamic ranges of physiological capacities (see earlier) tend to become narrower during
aging and senescence. Age-dependent KCC2 downregulation may also explain the improve-
ment of cognition that is achieved by reducing neuronal hyperexcitability with anticonvulsant
agents in elderly patients with mild cognitive impairment (MCI) [118]. Whether KCC2 down-
regulation is involved in the age-dependent loss of dendritic spines [119] in cortical neurons
is not known. Nevertheless, KCC2 may well turn out to be an important factor in the chain of
events which leads from MCI to major neurodegenerative diseases, including Alzheimer's
(e.g., [120]).
From a translational point of view, we call for wider recognition of themultifaceted roles of KCC2 in
neurodevelopmental disorders (see Outstanding Questions). Recent studies point to
malfunctions of both K-Cl cotransport as well as the actin-mediated effects of KCC2 in autism,
schizophrenia, and epilepsy [28,121,122]. Clearly, the multifunctionality of KCC2 deserves
more attention in work on putative therapeutic strategies based on KCC2-targeting drugs
[123,124] and gene manipulation [125].
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